1N9A image
Deposition Date 2002-11-22
Release Date 2003-01-07
Last Version Date 2024-02-14
Entry Detail
PDB ID:
1N9A
Keywords:
Title:
Farnesyltransferase complex with tetrahydropyridine inhibitors
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.20 Å
R-Value Free:
0.37
R-Value Work:
0.32
Space Group:
P 61
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Protein farnesyltransferase alpha subunit
Gene (Uniprot):Fnta
Chain IDs:A
Chain Length:315
Number of Molecules:1
Biological Source:Rattus norvegicus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Protein farnesyltransferase beta subunit
Gene (Uniprot):Fntb
Chain IDs:B
Chain Length:402
Number of Molecules:1
Biological Source:Rattus norvegicus
Primary Citation
Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency.
Bioorg.Med.Chem.Lett. 13 1363 1366 (2003)
PMID: 12657283 DOI: 10.1016/S0960-894X(03)00094-5

Abstact

Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered bioavailable aryl tetrahydropyridines that are potent in cell culture. The design, synthesis, SAR and biological properties of these compounds will be discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures